Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains P Riederer, E Sofic, WD Rausch, B Schmidt, GP Reynolds, K Jellinger, ... Journal of neurochemistry 52 (2), 515-520, 1989 | 1747 | 1989 |
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain E Sofic, P Riederer, H Heinsen, H Beckmann, GP Reynolds, ... Journal of neural transmission 74, 199-205, 1988 | 971 | 1988 |
Metabolic side effects of antipsychotic drug treatment–pharmacological mechanisms GP Reynolds, SL Kirk Pharmacology & therapeutics 125 (1), 169-179, 2010 | 584 | 2010 |
A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia ZJ Zhang, GP Reynolds Schizophrenia research 55 (1-2), 1-10, 2002 | 561 | 2002 |
Association of antipsychotic druginduced weight gain with a 5-HT2C receptor gene polymorphism GP Reynolds, ZJ Zhang, XB Zhang The Lancet 359 (9323), 2086-2087, 2002 | 538 | 2002 |
Neurochemical characteristics of early and late onset types of Alzheimer's disease. MN Rossor, LL Iversen, GP Reynolds, CQ Mountjoy, M Roth Br Med J (Clin Res Ed) 288 (6422), 961-964, 1984 | 528 | 1984 |
Human brain dopamine receptors in children and aging adults P Seeman, NH Bzowej, HC Guan, C Bergeron, LE Becker, GP Reynolds, ... Synapse 1 (5), 399-404, 1987 | 505 | 1987 |
Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics CL Beasley, GP Reynolds Schizophrenia research 24 (3), 349-355, 1997 | 502 | 1997 |
Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia GP Reynolds Nature 305 (5934), 527-529, 1983 | 497 | 1983 |
Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia JFW Deakin, P Slater, MDC Simpson, AC Gilchrist, WJ Skan, MC Royston, ... Journal of neurochemistry 52 (6), 1781-1786, 1989 | 479 | 1989 |
Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. P Seeman, NH Bzowej, HC Guan, C Bergeron, GP Reynolds, ED Bird, ... Neuropsychopharmacology: official publication of the American College of …, 1987 | 462 | 1987 |
Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins CL Beasley, ZJ Zhang, I Patten, GP Reynolds Biological psychiatry 52 (7), 708-715, 2002 | 444 | 2002 |
Bimodal distribution of dopamine receptor densities in brains of schizophrenics P Seeman, C Ulpian, C Bergeron, P Riederer, K Jellinger, E Gabriel, ... Science 225 (4663), 728-731, 1984 | 396 | 1984 |
Deprenyl is metabolized to methamphetamine and amphetamine in man. GP Reynolds, JD Elsworth, K Blau, M Sandler, AJ Lees, GM Stern British journal of clinical pharmacology 6 (6), 542, 1978 | 355 | 1978 |
Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis LA Templeman, GP Reynolds, B Arranz, L San Pharmacogenetics and genomics 15 (4), 195-200, 2005 | 341 | 2005 |
Effects of antipsychotics on fat deposition and changes in leptin and insulin levels: magnetic resonance imaging study of previously untreated people with schizophrenia ZJ Zhang, ZJ Yao, WEN Liu, QUN Fang, GP Reynolds The British journal of psychiatry 184 (1), 58-62, 2004 | 333 | 2004 |
Loss of pigmented dopamine-β-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type LL Iversen, MN Rossor, GP Reynolds, R Hills, M Roth, CQ Mountjoy, ... Neuroscience letters 39 (1), 95-100, 1983 | 332 | 1983 |
Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the ‘cheese effect’ JD Elsworth, V Glover, GP Reynolds, M Sandler, AJ Lees, P Phuapradit, ... Psychopharmacology 57, 33-38, 1978 | 319 | 1978 |
BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment SJ Cooper, GP Reynolds, With expert co-authors (in alphabetical order):, ... Journal of Psychopharmacology 30 (8), 717-748, 2016 | 274 | 2016 |
Polymorphism of the Promoter Region of the Serotonin 5-HT2C Receptor Gene and Clozapine-Induced Weight Gain GP Reynolds, ZJ Zhang, XB Zhang American Journal of Psychiatry 160 (4), 677-679, 2003 | 259 | 2003 |